Radiotherapy For Pancreatic Cancer | Products | Elekta

MR-guided radiation therapy (MRgRT) for pancreatic cancer

Escalate dose with certainty

Reduce margins to deliver ablative doses safely

Pancreatic cancer has one of the lowest overall survival rates of any cancer 1 . Currently, the standard of care for inoperable pancreatic cancer involves the use of non-ablative radiation doses, since the high doses required to completely eradicate tumors are deemed unsafe using conventional CT-guidance.

Elekta Unity supports the safe delivery of ablative radiation doses to pancreatic targets in just five sessions. MR-guided radiation therapy (MRgRT) enables you to see the tumor and surrounding OARs clearly for more accurate target delineation. With this superior soft tissue visualization and the ability to manage intrafraction motion, Elekta Unity allows the use of smaller margins–reducing dose to healthy tissue and supporting safe dose escalation.

The delivery of ablative doses by MRgRT has been shown to provide excellent local control for patients with inoperable pancreatic cancer, offering them a safe and effective treatment alternative.

Clinical benefits

Elekta Unity MR-guided radiation therapy for pancreatic cancer

With daily online plan adaptation and comprehensive motion management, Elekta Unity allows you to safely escalate dose and enhance outcomes for pancreatic cancer patients.

  • Safely deliver ablative doses (e.g. 50 Gy in 5 fractions)
  • Enhance targeting accuracy with inter- and intrafraction motion management
  • Spare surrounding sensitive structures and reduce toxicity
  • Increase treatment options for inoperable pancreatic cancer patients
  • Gain functional imaging insights to predict tumor response

See the difference for pancreatic cancer treatments

Clinical evidence

Learn more about how MR-guided radiation therapy is benefiting pancreatic cancer patients.

On CBCT you can’t distinguish the pancreas from the duodenum and bowel tissue, and you can’t visualize the tumor in the pancreas. On Elekta Unity, you can see the pancreas, the tumor and the duodenum. This is important because all these structures change position from day to day. With this information, you can change the patient’s treatment plan daily to compensate for these variations.

Prof. Dr. Martijn Intven
Radiation Oncologist at UMC Utrecht, The Netherlands


Find out more about
Elekta Unity

More than confident—certain

Elekta Unity
Elekta Unity


Explore the benefits of Elekta Unity for highlighted indications


2. Adapted from Tringale et al. Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system. doi: 10.1016/j.phro.2022.10.003. Licenced by CC B